FABP3 and peripheral arterial disease: There are new promising biomarkers, like the cardiac markers heart-type fatty acid binding protein, highly sensitive troponin T, and N-terminal pro b-type natriuretic peptide, and the inflammatory marker C-reactive protein, that have received considerable attention for the prognosis of PAD patients in recent years [20,23,24,25].